|
1
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type:
male:female differences diminishing and adenocarcinoma rates
rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cardona AF, Reveiz L, Ospina EG, et al:
Palliative endobronchial brachytherapy for non-small cell lung
cancer. Cochrane Database Syst Rev. CD004284:2008. View Article : Google Scholar
|
|
3
|
Ebara S, Katayama N, Tanimoto R, et al:
Iodine-125 seed implantation (permanent brachytherapy) for
clinically localized prostate cancer. Acta Med Okayama. 62:9–13.
2008.PubMed/NCBI
|
|
4
|
Nag S, DeHaan M, Scruggs G, Mayr N and
Martin EW: Long-term follow-up of patients of intrahepatic
malignancies treated with iodine-125 brachytherapy. Int J Radiat
Oncol Biol Phys. 64:736–744. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiller JH, Harrington D, Belani CP, et
al: Comparison of four chemotherapy regimens for advanced
non-small-cell lung cancer. N Engl J Med. 346:92–98. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen G and Bao Y: Sodium Glycididazole
Clinical Trial Cooperative Group: Double blind randomized clinical
trail phase II on the sensitization by sodium glycididazole
injection. Chin J Radiat Oncol. 12:254–258. 2003.(In Chinese).
View Article : Google Scholar
|
|
7
|
Wang XP, Yun S, Zhang XL and Ding W:
Primary clinical study of radiosensitizer CMNa. Chin Clin Oncol.
8:28–32. 2003.(In Chinese).
|
|
8
|
Zeng YC, Wu R, Xu ZG, et al: Safety and
radiation-enhancing effect of sodium glycididazole in
locoregionally advanced laryngeal cancers previously treated with
platinum-containing chemotherapy regimens: A preliminary report.
Cancer Radiother. 14:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu MZ, He LR, Lu TX, et al: Effect of
hypoxic radiosensitizer sodium glycididazole on long-term result of
radiotherapy for nasopharyngeal carcinoma. Chin J Oncol.
28:932–937. 2006.(In Chinese).
|
|
10
|
Yang J, Liu MZ, Cai L, et al: Phase II
clinical trial of sodium glyci-didazole (CM-Na) combined with
concurrent radiochemotherapy for advanced esophageal carcinoma.
Chin J Cancer. 622–626. 2008.(In Chinese).
|
|
11
|
He ZY, Li FY, Tong Q, Liao ZW, Guan XX and
Wang W: Concurrent chemoradiotherapy with sodium glycididazole and
cisplatin for local advanced nasopharyngeal carcinoma. J First Mil
Med Univ. 28:2038–2040. 2008.(In Chinese).
|
|
12
|
International Union Against Cancer (UICC):
Lung and Pleural TumoursTNM Classification of Malignant Tumours.
Sobin LH, Gospodarowicz MK and Wittekind C: 7th. Wiley-Blackwell;
New York, NY: pp. 99–106. 2009
|
|
13
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: revised
RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Cancer Institute, . Common
Terminology Criteria for Adverse Events (CTCAE) version 4.0.
Accessed. June 14–2010.
|
|
15
|
Hu XK, Wang MY, Yang ZG, et al: The study
of curing central-type lung cancer by CT guided percutaneous
embedding of 125I seeds. Chin J Radiol. 38:910–915. 2004.(In
Chinese).
|
|
16
|
Ling CC: Permanent implants using Au-198,
Pd-103 and I-125: radiobiological considerations based on the
linear quadratic model. Int J Radiat Oncol Biol Phys. 23:81–87.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blasko JC, Mate T, Sylvester JE, Grimm PD
and Cavanagh W: Brachytherapy for carcinoma of the prostate:
techniques, patient selection and clinical outcomes. Semin Radiat
Oncol. 12:81–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Henry AM, Al-Qaisieh B, Gould K, et al:
Outcomes following iodine-125 monotherapy for localized prostate
cancer: the results of Leeds 10-year single-center brachytherapy
experience. Int J Radiat Oncol Biol Phys. 76:50–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kubota K, Nishiwaki Y, Ohashi Y, et al:
The Four-Arm Cooperative Study (FACS) for advanced non-small cell
lung cancer (NSCLC). J Clin Oncol (Meeting Abstracts). 22
(Suppl):70062004.
|
|
20
|
Vokes EE, Choy H, Gandara D and Mattson K:
Adjuvant and neoadjuvant treatments for NSCLC. Lung Cancer. 38
(Suppl 4):29–35. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen A, Galloway M, Landreneau R, et al:
Intraoperative 125I brachytherapy for high-risk stage I non-small
cell lung carcinoma. Int J Radiat Oncol Biol Phys. 44:1057–1063.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Depierre A, Milleron B, Moro-Sibilot D, et
al: French Thoracic Cooperative Group: Preoperative chemotherapy
followed by surgery compared with primary surgery in resectable
stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J
Clin Oncol. 20:247–253. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng X, Meng X, Zhao F, LI Y and GAO J:
The in situ tumor response to radiosensitization of a novel
sensitizer sodium glycididazole. J Radiat Res Radiat Process.
18:91–95. 2000.(In Chinese).
|
|
24
|
Zhang X, Ji HB, Chen ZH, OuYang XN and
Yang RJ: Lung cancer radiosensitization by CMNa in vitro and in
vivo. Chin J Radiol Med and Prot. 25:316–318. 2005.(In
Chinese).
|
|
25
|
Lei KJ, Wang J, Jia YM and Cao YY:
Chemo-sensitivity-enhancing effects of low dose glycididazolum
natrium on patients with advanced non-small cell lung cancer during
intervention. Chinese-German J Clin Oncol. 9:385–387. 2010.(In
Chinese). View Article : Google Scholar
|
|
26
|
Lei KJ, Jia YM, Wang J and Du YP: Effects
of CMNa combined with paclitaxel and carboplatin on elevated CA12-5
levels in post-operation advanced ovarian cancer patients.
Chinese-German J Clin Oncol. 7:600–602. 2008.(In Chinese).
View Article : Google Scholar
|
|
27
|
Brach B, Buhler C, Hayman MH, Joyner LR Jr
and Liprie SF: Percutaneous computed tomography-guided fine needle
brachytherapy of pulmonary malignancies. Chest. 106:268–274. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martinez-Monge R, Pagola M, Vivas I and
Lopez-Picazo JM: CT-guided permanent brachytherapy for patients
with medically inoperable early-stage non-small cell lung cancer
(NSCLC). Lung Cancer. 61:209–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lewis JW Jr, Ajlouni M, Kvale PA, et al:
Role of brachytherapy in the management of pulmonary and
mediastinal malignancies. Ann Thorac Surg. 49:728–733. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu LQ, Huang F, Guo JH, et al: Phase I
clinical pharmacokinetics of glycididazolum natrium. Chin J Pharm
Toxicol. 18:87–92. 2004.(In Chinese).
|
|
31
|
Gao HJ, Shen G, Wang HM, et al: Phase I
clinical trail of sodium glycididadole (CMNa) in cancer patients.
Chin J New Drugs. 13:260–263. 2004.(In Chinese).
|
